Cart
sales@molnova.com
Methyl Oleate
CAS No. 112-62-9
Methyl Oleate( —— )
Catalog No. M17828 CAS No. 112-62-9
Methyl Oleate is an unsaturated high fatty acid ester, an important chemical raw material, widely used in the preparation of surfactants, leather additives, textile additives, as well as insecticide additives.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product NameMethyl Oleate
-
NoteResearch use only, not for human use.
-
Brief DescriptionMethyl Oleate is an unsaturated high fatty acid ester, an important chemical raw material, widely used in the preparation of surfactants, leather additives, textile additives, as well as insecticide additives.
-
DescriptionMethyl Oleate is an unsaturated high fatty acid ester, an important chemical raw material, widely used in the preparation of surfactants, leather additives, textile additives, as well as insecticide additives.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number112-62-9
-
Formula Weight296.49
-
Molecular FormulaC19H36O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (337.28 mM)
-
SMILESCCCCCCCCC=CCCCCCCCC(=O)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
HS220
HS220 is an inhibitor of TAK1 which plays a key role in the signaling pathways of inflammation and cell survival.
-
BMS-751324
BMS-751324 is a novel clinical prodrug of BMS-582949, which is a highly selective p38α MAPK inhibitor with IC50 of 13 nM.
-
PH797804
PH-797804 is a novel pyridinone inhibitor of p38α with IC50 of 26 nM in a cell-free assay; 4-fold more selective versus p38β and does not inhibit JNK2. Phase 2.
